Global HEOR Director, Ritlecitinib (Immunology and Inflammation)
To support the strategic goals of the Inflammation & Immunology (I&I) Business Unit (BU) by providing strategic guidance and robust evidence development and communication to demonstrate the value of ritlecitinib in Alopecia Areata (AA) and secure optimal global patient access. This role will serve as the Global HEOR Director to support product development and launch for ritlecitinib in AA and will report to the Integrated Team Leader (ITL) – PHI – Ritlecitinib.
The HEOR Director will function with a One PHI mindset and will work in a closely aligned fashion with the ITL – PHI – Ritlecitinib, I&I PHI Cross-functional Leadership Team (CFLT), and other functional areas within PHI as well as the brand team to ensure there is a single and coordinated view on strategy and delivery for PHI to the I&I business. The HEOR Director will be a strategic partner to Global Product Development, Commercial Development, Global Medical, and other cross-functional teams to develop and implement a HEOR strategy that supports and help communicate the overall asset value proposition. Within PHI, the HEOR director will collaborate closely with country colleagues.
Independently deliver strategic thinking from an HEOR perspective in support of our medicines; operate with a significant amount of autonomy
Be a Strategic Partner to cross-functional teams and provide HEOR leadership in cross-functional strategy meetings
Independently initiate and lead the development and execution of a multi-year HEOR strategy that includes projects and cutting edge studies (e.g., real-world non-interventional studies, registries, etc.) to support the value of our medicines in close partnership with the cross-functional matrix team.
Incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence in line with overall medical strategy for the assets and to ensure global reimbursement and access requirements.
Provide strategic input in the selection of relevant patient population and comparators within clinical trials to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers.
Lead the development and validation of new Patient Reported Outcomes (PRO) measures as appropriate, and the analyses, interpretation, and communication of existing PRO measures across clinical trials, registries, and prospective real-world studies.
Identify opportunities to partner with I&I BU external customers to conduct HEOR projects in support of asset strategies
Lead the timely development of deliverables including global value dossiers (GVDs), evidence blueprints, economic models, and innovative tools to successfully support global launch, reimbursement and access requirements in conjunction with the regions/countries.
Lead the coordination of input from local country/regional HEOR teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrated evidence strategy to support global market access needs at time of launch.
Develop real world evidence generation strategies and flawlessly execute studies (e.g., burden of illness studies, epidemiology studies, etc.) to generate evidence to support brand competitive differentiation and value proposition.
Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community settings to support asset strategies.
Collaborate with local health and value affiliates and enable local model adaptations and updates throughout the product life cycle.
Provide strategic guidance and content guidance in reimbursement (re)negotiations for Pfizer products.
Lead the development of appropriate data dissemination plans and communicate evidence generated via publications and conference presentations.
Prepare clear, relevant, and influential written reports and presentations for a variety of audiences and effectively present information to management at Pfizer.
Represent Pfizer at appropriate scientific, medical, payer, patient & other meetings, as appropriate.
Execute in a manner that is compliant, with integrity, and follows the appropriate SOPs and Engagement policies
Optimal project Budget management
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact
Minimum Masters degree (MSc, MPH) in health services research, public health, epidemiology, or health economics with a preferred Doctoral degree (PhD, DrPH, ScD) in health services research, public health, epidemiology, or health economics.
Minimum 8 years’ experience in health outcomes and related fields, 5 of which are as part of global health economics and/or outcomes research teams in a pharmaceutical company.
Strong working knowledge of the technical and methodological aspects of registries and observational study design and implementation. Capable of independently managing complex registry and non-interventional study projects.
Strong methodological skills (study design, data analysis and interpretation) in clinical trials, epidemiology, or health services research is required
Experience with PRO measurement and analysis is strongly preferred
Knowledge and experience in the I&I therapeutic area and specifically in dermatology is preferred
Experience with global launches is preferred
Experience with HTA organizations such as NICE, SMC, PBAC is expected
Experience with US Health Care System is desirable
Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers
Excellent oral and written English communication skills required
Strong project management abilities (contracting, budgeting, vendor management) essential. Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
Ability to influence key members of medical and commercial teams constructively and without conflict
Skilled in functioning within a matrix organization where managing through influence is required
Other Job Details:
Last Date to Apply for Job: August 13th 2021
Additional Location Information: New York, NY; Collegeville, PA
NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS
Ability to travel internationallySunshine ActPfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.EEO & Employment EligibilityPfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.Market Access#LI-PFE